Passive investing in index funds may match market returns, but selecting high-performing stocks can outperform. Agios Pharmaceuticals (NASDAQ: AGIO) shares surged 71% in the last year, driven by a 55% revenue growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing